These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 18164975)
1. Arterial and venous thrombotic complications with thalidomide in multiple myeloma. Alkindi S; Dennison D; Pathare A Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975 [No Abstract] [Full Text] [Related]
2. Thalidomide therapy and deep venous thrombosis in multiple myeloma. Rajkumar SV Mayo Clin Proc; 2005 Dec; 80(12):1549-51. PubMed ID: 16350272 [No Abstract] [Full Text] [Related]
3. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature. Martin MG; Vij R Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384 [TBL] [Abstract][Full Text] [Related]
4. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157 [TBL] [Abstract][Full Text] [Related]
5. Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin. Chennuru S; Baumann MA Intern Med J; 2007 Jul; 37(7):506-7. PubMed ID: 17547733 [No Abstract] [Full Text] [Related]
6. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Baz R; Li L; Kottke-Marchant K; Srkalovic G; McGowan B; Yiannaki E; Karam MA; Faiman B; Jawde RA; Andresen S; Zeldis J; Hussein MA Mayo Clin Proc; 2005 Dec; 80(12):1568-74. PubMed ID: 16342649 [TBL] [Abstract][Full Text] [Related]
7. [Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide]. Esteve E; Legac E Ann Dermatol Venereol; 2001 Feb; 128(2):148-9. PubMed ID: 11275595 [No Abstract] [Full Text] [Related]
8. Thromboembolism in patients on thalidomide for myeloma. Bowcock SJ; Rassam SM; Ward SM; Turner JT; Laffan M Hematology; 2002 Feb; 7(1):51-3. PubMed ID: 12171777 [TBL] [Abstract][Full Text] [Related]
9. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone]. Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma. Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478 [TBL] [Abstract][Full Text] [Related]
11. Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study. Offidani M; Marconi M; Corvatta L; Olivieri A; Catarini M; Leoni P Haematologica; 2003 Dec; 88(12):1432-3. PubMed ID: 14688003 [No Abstract] [Full Text] [Related]
12. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation. Zangari M; Barlogie B; Anaissie E; Saghafifar F; Eddlemon P; Jacobson J; Lee CK; Thertulien R; Talamo G; Thomas T; Van Rhee F; Fassas A; Fink L; Tricot G Br J Haematol; 2004 Sep; 126(5):715-21. PubMed ID: 15327525 [TBL] [Abstract][Full Text] [Related]
13. Desensitization to thalidomide in a patient with multiple myeloma. Nucera E; Schiavino D; Hohaus S; Leone G; Buonomo A; Lombardo C; Patriarca G Clin Lymphoma Myeloma; 2008 Jun; 8(3):176-8. PubMed ID: 18650182 [TBL] [Abstract][Full Text] [Related]
15. Deep venous thrombosis and thalidomide therapy for multiple myeloma. Osman K; Comenzo R; Rajkumar SV N Engl J Med; 2001 Jun; 344(25):1951-2. PubMed ID: 11419443 [No Abstract] [Full Text] [Related]
16. Pulmonary embolism in a patient with multiple myeloma receiving thalidomide-dexamethasone therapy. Jeng WJ; Kuo MC; Shih LY; Chu PH Int J Hematol; 2008 Jun; 87(5):542-544. PubMed ID: 18414984 [TBL] [Abstract][Full Text] [Related]
17. Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome? Katodritou E; Gastari V; Verrou E; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Laschos K; Xirou P; Yiannaki E; Constantinou N; Markala D; Zervas K Leuk Res; 2009 Aug; 33(8):1137-40. PubMed ID: 19250676 [TBL] [Abstract][Full Text] [Related]
18. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature. Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795 [TBL] [Abstract][Full Text] [Related]
19. Very low doses of thalidomide as single agent in relapsed/refractory multiple myeloma. Guglielmelli T; Capella S; Saglio G Acta Haematol; 2006; 116(1):70-1. PubMed ID: 16809894 [No Abstract] [Full Text] [Related]
20. [Thrombotic accidents induced by thalidomide: two cases]. Gachon J; Grob JJ; Richard MA Rev Med Interne; 2002 Aug; 23(8):724-7. PubMed ID: 12360755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]